4-122897116-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001361665.2(FGF2):c.*4720A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.911 in 152,554 control chromosomes in the GnomAD database, including 63,452 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.91 ( 63283 hom., cov: 32)
Exomes 𝑓: 0.94 ( 169 hom. )
Consequence
FGF2
NM_001361665.2 3_prime_UTR
NM_001361665.2 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.158
Publications
9 publications found
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]
NUDT6 (HGNC:8053): (nudix hydrolase 6) This gene overlaps and lies on the opposite strand from FGF2 gene, and is thought to be the FGF2 antisense gene. The two genes are independently transcribed, and their expression shows an inverse relationship, suggesting that this antisense transcript may regulate FGF2 expression. This gene has also been shown to have hormone-regulatory and antiproliferative actions in the pituitary that are independent of FGF2 expression. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.945 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FGF2 | NM_001361665.2 | c.*4720A>T | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000644866.2 | NP_001348594.1 | ||
| NUDT6 | NM_007083.5 | c.553+508T>A | intron_variant | Intron 4 of 4 | ENST00000304430.10 | NP_009014.2 | ||
| FGF2 | NM_002006.6 | c.*4720A>T | 3_prime_UTR_variant | Exon 3 of 3 | NP_001997.5 | |||
| NUDT6 | NM_198041.3 | c.46+508T>A | intron_variant | Intron 4 of 4 | NP_932158.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.910 AC: 138440AN: 152058Hom.: 63235 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
138440
AN:
152058
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.944 AC: 357AN: 378Hom.: 169 Cov.: 0 AF XY: 0.942 AC XY: 196AN XY: 208 show subpopulations
GnomAD4 exome
AF:
AC:
357
AN:
378
Hom.:
Cov.:
0
AF XY:
AC XY:
196
AN XY:
208
show subpopulations
African (AFR)
AF:
AC:
6
AN:
8
American (AMR)
AF:
AC:
8
AN:
10
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
2
East Asian (EAS)
AF:
AC:
23
AN:
24
South Asian (SAS)
AF:
AC:
16
AN:
18
European-Finnish (FIN)
AF:
AC:
21
AN:
24
Middle Eastern (MID)
AF:
AC:
2
AN:
2
European-Non Finnish (NFE)
AF:
AC:
271
AN:
280
Other (OTH)
AF:
AC:
9
AN:
10
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.910 AC: 138548AN: 152176Hom.: 63283 Cov.: 32 AF XY: 0.909 AC XY: 67644AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
138548
AN:
152176
Hom.:
Cov.:
32
AF XY:
AC XY:
67644
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
35022
AN:
41526
American (AMR)
AF:
AC:
13380
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
3192
AN:
3470
East Asian (EAS)
AF:
AC:
4979
AN:
5190
South Asian (SAS)
AF:
AC:
4411
AN:
4816
European-Finnish (FIN)
AF:
AC:
9834
AN:
10594
Middle Eastern (MID)
AF:
AC:
237
AN:
286
European-Non Finnish (NFE)
AF:
AC:
64672
AN:
67988
Other (OTH)
AF:
AC:
1911
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
632
1265
1897
2530
3162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3244
AN:
3450
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.